Cargando…
Limited value of serum neurofilament light chain in diagnosing amyotrophic lateral sclerosis
A biomarker specific for the diagnosis of amyotrophic lateral sclerosis must be sensitive across a spectrum of clinical heterogeneity. Neurofilament light chain levels in amyotrophic lateral sclerosis correlate with the rate of disability progression. Previous attempts to establish a diagnostic role...
Autores principales: | Davies, Jennifer C, Dharmadasa, Thanuja, Thompson, Alexander G, Edmond, Evan C, Yoganathan, Katie, Gao, Jiali, Talbot, Kevin, Turner, Martin R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244039/ https://www.ncbi.nlm.nih.gov/pubmed/37292457 http://dx.doi.org/10.1093/braincomms/fcad163 |
Ejemplares similares
-
Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain
por: Thompson, Alexander G., et al.
Publicado: (2022) -
Creatine kinase and prognosis in amyotrophic lateral sclerosis: a literature review and multi-centre cohort analysis
por: Gao, Jiali, et al.
Publicado: (2022) -
Functional Biomarkers for Amyotrophic Lateral Sclerosis
por: Huynh, William, et al.
Publicado: (2019) -
Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis
por: Lu, Ching-Hua, et al.
Publicado: (2015) -
Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal
por: Benatar, Michael, et al.
Publicado: (2022)